Background illustration for clinical trials search

Sarcoma Clinical Trials

Browse 918 sarcoma clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease

for
Lymphoma, Primary Effusion
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT05907759

Phase2, Recruiting

Open-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone Lymphoma

for
Marginal Zone Lymphoma
Location: Miami FL, Atlanta GA, Nashvile TN, Duarte CA
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT05296070

Phase2, Recruiting

CTCL Directed Therapy

for
Lymphoma, T-Cell, Cutaneous
Location: Bronx NY
Sponsor: James J. Peters Veterans Affairs Medical Center

Sex: All

Age: 30 - 70+

Code: NCT03116659

Early_phase1, Recruiting

Acalabrutinib and Venetoclax With or Without Early Obinutuzumab for the Treatment of High Risk, Recurrent, or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

for
Recurrent Chronic Lymphocytic Leukemia,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04169737

Phase2, Recruiting

Reduced Dose Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma

for
Indolent B-Cell Non-Hodgkin Lymphoma,
Location: Jacksonville FL, La Crosse WI, Eau Claire WI,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06386315

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas

for
B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma,
Location: Montreal
Sponsor: Iksuda Therapeutics Ltd.

Sex: All

Age: 18+

Code: NCT05365659

Phase1, Recruiting

A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer

for
Unresectable, Locally Advanced, Metastatic Cancers,
Location: Quebec, Toronto, Cleveland OH, West Valley City UT,
Sponsor: Recursion Pharmaceuticals Inc.

Sex: All

Age: 12+

Code: NCT06678659

Phase1, Phase2, Recruiting

Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)

for
Medulloblastoma, Childhood,
Location: Washington D.C. DC
Sponsor: Children's National Research Institute

Sex: All

Age: 1 - 30

Code: NCT06193759

Phase1, Recruiting

Imatinib TDM in GIST

for
Gastrointestinal Stromal Tumors
Location: Lexington KY
Sponsor: Reema A. Patel

Sex: All

Age: 18+

Code: NCT05493215

Phase2, Recruiting

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

for
Chronic Lymphocytic Leukemia (CLL),
Location: Bethesda MD, Nashville TN, Chicago IL, Houston TX,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04830137

Phase1, Recruiting

Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin Lymphomas

for
Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma,
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT04883437

Phase2, Recruiting

AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas

for
Follicular Lymphoma, Mantle Cell Lymphoma, Hairy Cell Leukemia,
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT06340737

Phase1, Recruiting

Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma

for
Osteosarcoma, Pulmonary Recurrence of Osteosarcoma
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 0 - 50

Code: NCT06492954

Phase1, Recruiting

Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma

for
Recurrent Follicular Lymphoma, Refractory Follicular Lymphoma
Location: Sacramento CA
Sponsor: University of California, Davis

Sex: All

Age: 18+

Code: NCT04587687

Phase2, Recruiting

Acalabrutinib, Venetoclax and Durvalumab for the Treatment of Richter Transformation From Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

for
Chronic Lymphocytic Leukemia, Richter Syndrome,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT05388006

Phase2, Recruiting

Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas

for
Follicular Lymphoma, Marginal Zone Lymphoma, B-Cell Lymphoma
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT06350318

Phase2, Recruiting

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

for
Hematologic Malignancy, AML, ALL, BPDCN, MDS,
Location: New York NY, Washington DC, Ann Arbor MI, Cincinnati OH,
Sponsor: Therapeutic Advances in Childhood Leukemia Consortium

Sex: All

Age: 1 - 21

Code: NCT05476770

Phase1, Recruiting

Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma

for
B-cell Lymphoma, Burkitt Lymphoma,
Location: Valhalla NY
Sponsor: New York Medical College

Sex: All

Age: 12 - 70

Code: NCT04491370

Phase1, Phase2, Recruiting

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

for
Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma,
Location: New York NY, Richmond VA, Webster NY, Rochester NY,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05890352

Phase2, Recruiting

Baker Gordon Syndrome Natural History Study

for
Rare Diseases, Autism or Autistic Traits, Development Delay,
Location: Columbia MO
Sponsor: University of Missouri-Columbia

Sex: All

Age: 0 - 70+

Code: NCT06399952

Recruiting